#ASCO24 News: We are excited to announce data from the pivotal Phase 2 TRUST-I study of our investigational ROS1 inhibitor for #NSCLC are published in the American Society of Clinical Oncology (ASCO) Journal of Clinical Oncology. If you’re in Chicago, we hope to see you at the oral presentation today at 4:30 p.m. CT. Read more: https://lnkd.in/eKaZ3dkg #oncology #cancer
Nuvation Bio’s Post
More Relevant Posts
-
The April issue of ONCOLOGY is available and ready to download. This month features a clinical quandary focused on testicular cancer, QAs with Drs Robert A Winn and Omid Hamid, and the letter to readers from Dr Neil M Iyengar. https://lnkd.in/ebiNjj2T #cancer #oncology
-
Yardena Samuels discusses how ongoing research is revisiting the classic neoantigen approach - ESMO - European Society for Medical Oncology https://lnkd.in/g8YDjY8Q #oncodaily #oncology #cancer #research #neoantigens #cancerimmunotherapy #immunotherapy
-
Our commentary on the Global Summit on War and Cancer is now published in the Journal of Global Oncology! - Jemma Arakelyan https://lnkd.in/gdwv8gVj #oncodaily #oncology #cancer #research #GlobalSummitonWarandCancer
Jemma Arakelyan: Our commentary on the Global Summit on War and Cancer is now published in the Journal of Global Oncology! - OncoDaily
oncodaily.com
-
Technology & Solution Provider | Business Development | Sales Growth | Ambitious | Lifesciences Learner | Revenue Oriented | Client centric | Adaptive Sales | Quick Learner | Enthusiastic | Strategic Sales
CANCER- Come, Let's Unlock the power of Precision medicine.This time it is Hyderabad! Grandeur than ever! Connecting Onco-Genomics. #Oncology #Medical #Cancer #ISMPO #HYDERABAD #Hospitals #Genomics #CGP #Precisionmedicine #Tumourboard #CancerResearch #Diagnostics #Healthcare #MedEd #Medicine #Symposium #illumina
Join us as we bring together the eminent experts and leading practitioners from the field of oncology delving into transformative discussions around the power of CGP in precision oncology. This is an invite-only event. Reach out to sristhi@premaslifesciences.com if you would like to register for the symposia in Hyderabad. Illumina #CGP #oncology #cancer #precisiononcology #Hyderabad #dinnersymposia
-
-
Medical Doctor na European Association of Nuclear Medicine (EANM)
Joint EANM‑SNMMI guideline on the role of 2‑[18F]FDG PET/CT in no special type breast cancer (endorsed by the ACR, ESSO, ESTRO, EUSOBI/ESR, and EUSOMA) - Summary of the 2-[18F]FDG PET/CT recommendations according to the clinical scenario in NST breast cancer
-
-
With over 19,000 new cases each year and a 5-year survival rate below 50%, functional precision oncology for ovarian cancer is essential. Our 3D Predict™ test can be used to personalize chemotherapy for effective first-line treatments, ensuring each patient gets care tailored to their unique needs. Learn more: bit.ly/3SJjrxy #Kiyatec #3DPredict #PrecisionOncology #OvarianCancer
-
-
Fantastic discussion on biomarker testing and precison oncology - Rafeh Naqash Ignacio Garrido-Laguna, MD, PhD, MBA Sunnie Kim Pashtoon Kasi https://lnkd.in/dE4frPjY #Cancer #ColorectalCancer #OncoDaily #Oncology #PrecisonOncology
-
-
A must-read Precision Oncology: 2023 in Review - Norbert Kraut https://lnkd.in/eWZ35xVp #Cancer #CancerDiscovery #OncoDaily #Oncology #PrecisionOncology #CancerCare
-
-
Our commentary on the state of play of radiomics in Precision Oncology - Melvin L.K. Chua #Cancer #OncoDaily #Oncology #PrecisionMedicine #CancerCare
Melvin LK Chua: Our commentary on the state of play of radiomics in Precision Oncology - Oncodaily | Oncology News, Insights, Stories
oncodaily.com
-
Stay Informed about EORTC News! 🌟 Would you like to stay updated about our latest breakthroughs in clinical cancer research, upcoming events and more? Then don't miss out on our biannual newsletter, your source for the latest EORTC updates. 📰 Subscribe now: https://lnkd.in/eTrmWTfP #CancerResearch #ClinicalTrials #Oncology #Newsletter #EORTCNews
-
R&D, Drug Development & Medical Affairs, Market Access Global Clinical Studies and Product Marketing Lifecycle Management across the Globe, Regulatory Advisor
1moSee you there!